• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

可生物吸收支架展望——它的进步有多大？

The Bioresorbable Stent in Perspective-How Much of an Advance is It?

作者信息

Kočka Viktor, Widimský Petr

机构信息

Cardiocenter, Third Faculty of Medicine, Charles University, Prague, University Hospital Kralovske Vinohrady, Czech Republic.

出版信息

Interv Cardiol. 2014 Mar;9(1):23-25. doi: 10.15420/icr.2011.9.1.23.

DOI:10.15420/icr.2011.9.1.23
PMID:29588773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5808682/
Abstract

The novel idea of bioresorbable stent technology continues to fascinate the interventional community. This article aims to provide a concise and balanced overview of the available technology and clinical evidence. Both potentially positive and negative aspects of bioresorbable stents in different lesion subsets and clinical situations are discussed.

摘要

生物可吸收支架技术这一新颖理念持续吸引着介入治疗领域。本文旨在对现有技术和临床证据进行简明且全面的概述。文中讨论了生物可吸收支架在不同病变亚组和临床情形中潜在的积极和消极方面。

相似文献

1
The Bioresorbable Stent in Perspective-How Much of an Advance is It?可生物吸收支架展望——它的进步有多大？
Interv Cardiol. 2014 Mar;9(1):23-25. doi: 10.15420/icr.2011.9.1.23.
2
Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.依维莫司洗脱生物可吸收血管支架与依维莫司洗脱金属支架的比较：随机对照试验的荟萃分析。
Lancet. 2016 Feb 6;387(10018):537-544. doi: 10.1016/S0140-6736(15)00979-4. Epub 2015 Nov 17.
3
Vascular restoration therapy and bioresorbable vascular scaffold.血管修复治疗和生物可吸收血管支架。
Regen Biomater. 2014 Nov;1(1):49-55. doi: 10.1093/rb/rbu005. Epub 2014 Oct 20.
4
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.对比依维莫司洗脱生物可吸收支架与依维莫司洗脱金属支架治疗冠状动脉狭窄的疗效（ABSORB II）：3 年随机、对照、单盲、多中心临床试验。
Lancet. 2016 Nov 19;388(10059):2479-2491. doi: 10.1016/S0140-6736(16)32050-5. Epub 2016 Oct 30.
5
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.生物可吸收依维莫司洗脱支架与金属依维莫司洗脱支架治疗初发原生冠状动脉病变所致缺血性心脏病的比较（ABSORB II）：一项随机对照临床试验的临床和操作次要终点 1 年中期分析。
Lancet. 2015 Jan 3;385(9962):43-54. doi: 10.1016/S0140-6736(14)61455-0. Epub 2014 Sep 14.
6
The Current Literature on Bioabsorbable Stents: a Review.生物可吸收支架的最新文献综述。
Curr Atheroscler Rep. 2019 Nov 25;21(12):54. doi: 10.1007/s11883-019-0816-4.
7
Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.生物可吸收支架与金属支架在常规 PCI 中的应用比较。
N Engl J Med. 2017 Jun 15;376(24):2319-2328. doi: 10.1056/NEJMoa1614954. Epub 2017 Mar 29.
8
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial.冠状动脉血运重建患者中应用超薄可生物吸收聚合物西罗莫司洗脱支架与薄型持久聚合物依维莫司洗脱支架（BIOFLOW V）：一项随机试验
Lancet. 2017 Oct 21;390(10105):1843-1852. doi: 10.1016/S0140-6736(17)32249-3. Epub 2017 Aug 26.
9
Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.经皮冠状动脉介入治疗后的边缘血管反应：血管内超声和光学相干断层成像评估——从放射性平台到第一代和第二代药物洗脱支架和生物可吸收支架。
JACC Cardiovasc Interv. 2013 Mar;6(3):211-21. doi: 10.1016/j.jcin.2013.01.132.
10
Mechanical properties and degradation of drug eluted bioresorbable vascular scaffolds prepared by three-dimensional printing technology.采用三维打印技术制备的药物洗脱生物可吸收血管支架的力学性能及降解
J Biomater Sci Polym Ed. 2019 May;30(7):547-560. doi: 10.1080/09205063.2019.1586303. Epub 2019 Apr 7.

本文引用的文献

1
Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months.依维莫司洗脱可吸收生物可降解血管支架植入后血管壁变化的动态研究：一项在6个月、12个月、24个月和36个月时进行的多成像模态研究
EuroIntervention. 2014 Mar 20;9(11):1271-84. doi: 10.4244/EIJV9I11A217.
2
Bioresorbable vascular scaffolds in cardiac allograft vasculopathy: a new therapeutic option.生物可吸收血管支架在心脏移植血管病变中的应用：一种新的治疗选择。
Am J Med. 2013 Nov;126(11):e11-4. doi: 10.1016/j.amjmed.2013.05.025.
3
Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold.使用依维莫司洗脱生物可吸收血管支架治疗的ST段抬高型心肌梗死（STEMI）患者的短期预后
Clin Res Cardiol. 2014 Feb;103(2):141-8. doi: 10.1007/s00392-013-0630-x. Epub 2013 Oct 18.
4
Three-dimensional optical coherence tomography evaluation of a left main bifurcation lesion treated with ABSORB® bioresorbable vascular scaffold including fenestration and dilatation of the side branch.使用ABSORB®生物可吸收血管支架治疗左主干分叉病变的三维光学相干断层扫描评估，包括侧支开窗和扩张。
Int J Cardiol. 2013 Oct 3;168(3):e107-8. doi: 10.1016/j.ijcard.2013.07.255. Epub 2013 Aug 2.
5
Successful retrograde recanalization of chronic total coronary occlusion with multiple bioresorbable vascular scaffolds ('full polymer jacket'): initial experience and rationale.使用多个生物可吸收血管支架（“全聚合物外套”）成功逆行再通慢性完全性冠状动脉闭塞：初步经验及理论依据
Eur Heart J. 2013 Oct;34(37):2925. doi: 10.1093/eurheartj/eht319. Epub 2013 Aug 20.
6
Multislice computed tomography angiography for noninvasive assessment of the 18-month performance of a novel radiolucent bioresorbable vascular scaffolding device: the ABSORB trial (a clinical evaluation of the bioabsorbable everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).多层螺旋计算机断层扫描血管造影术用于无创评估一种新型可透射线生物可吸收血管支架装置的18个月性能：ABSORB试验（生物可吸收依维莫司洗脱冠状动脉支架系统治疗初发原发性冠状动脉病变患者的临床评估）
J Am Coll Cardiol. 2013 Nov 5;62(19):1813-4. doi: 10.1016/j.jacc.2013.07.030. Epub 2013 Aug 7.
7
ST elevation myocardial infarction treated with bioresorbable vascular scaffold: rationale and first cases.生物可吸收血管支架治疗ST段抬高型心肌梗死：原理及首例病例
Eur Heart J. 2013 Jul;34(27):2073. doi: 10.1093/eurheartj/eht168. Epub 2013 May 31.
8
Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI).生物可吸收雷帕霉素洗脱血管支架（BVS）在 ST 段抬高型心肌梗死（STEMI）患者中的植入。
EuroIntervention. 2013 Aug 22;9(4):501-4. doi: 10.4244/EIJV9I4A80.
9
"First-in-man" use of bioresorbable vascular scaffold in saphenous vein graft.
EuroIntervention. 2013 May 20;9(1):165. doi: 10.4244/EIJV9I1A24.
10
Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials.在 ABSORB-EXTEND 单臂试验中，435 例患者接受依维莫司洗脱生物可吸收血管支架治疗后小分支闭塞的发生率及短期临床结局：与 SPIRIT 试验 I 和 II 中依维莫司洗脱金属支架的比较。
JACC Cardiovasc Interv. 2013 Mar;6(3):247-57. doi: 10.1016/j.jcin.2012.10.013.